SE9502893L - Användning av kollagenas - Google Patents

Användning av kollagenas

Info

Publication number
SE9502893L
SE9502893L SE9502893A SE9502893A SE9502893L SE 9502893 L SE9502893 L SE 9502893L SE 9502893 A SE9502893 A SE 9502893A SE 9502893 A SE9502893 A SE 9502893A SE 9502893 L SE9502893 L SE 9502893L
Authority
SE
Sweden
Prior art keywords
collagenase
dupuytren
disease
affected
treated
Prior art date
Application number
SE9502893A
Other languages
Unknown language ( )
English (en)
Swedish (sv)
Other versions
SE9502893D0 (sv
Inventor
Thomas L Wegman
Original Assignee
Advance Biofactures Curacao
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Advance Biofactures Curacao filed Critical Advance Biofactures Curacao
Publication of SE9502893D0 publication Critical patent/SE9502893D0/xx
Publication of SE9502893L publication Critical patent/SE9502893L/

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/4886—Metalloendopeptidases (3.4.24), e.g. collagenase

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Medicines Containing Plant Substances (AREA)
SE9502893A 1994-08-22 1995-08-21 Användning av kollagenas SE9502893L (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08/294,097 US5589171A (en) 1994-08-22 1994-08-22 Treatment of Dupuytren's disease with collagenase

Publications (2)

Publication Number Publication Date
SE9502893D0 SE9502893D0 (sv) 1995-08-21
SE9502893L true SE9502893L (sv) 1996-02-23

Family

ID=23131866

Family Applications (1)

Application Number Title Priority Date Filing Date
SE9502893A SE9502893L (sv) 1994-08-22 1995-08-21 Användning av kollagenas

Country Status (7)

Country Link
US (1) US5589171A (da)
DE (1) DE19530832A1 (da)
DK (1) DK89395A (da)
FI (1) FI953915A7 (da)
GB (1) GB2292521A (da)
NO (1) NO953262L (da)
SE (1) SE9502893L (da)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6958150B2 (en) 1994-12-15 2005-10-25 Advance Biofactures Of Curacao, N.V. Reduction of adipose tissue
US6086872A (en) * 1997-03-27 2000-07-11 Advance Biofactures Of Curacao, Nv Amelioration of dupuytren's disease
US20070224184A1 (en) * 2006-02-22 2007-09-27 The Research Foundation Of The State University Of New York Method for treating cellulite
CA2593038C (en) * 2005-01-21 2015-03-17 Advance Biofactures Corporation Methods for treating adhesive capsulitis
ITPD20050207A1 (it) 2005-07-07 2007-01-08 Fidia Farmaceutici Nuove composizioni farmaceutiche contenenti acido ialuronico e collagenas nel trattamento topico di ferite, ustioni ed ulcere
US7811560B2 (en) 2006-01-30 2010-10-12 Auxilium Us Holdings, Llc Compositions and methods for treating collagen-mediated diseases
US20080233614A1 (en) * 2007-02-13 2008-09-25 Cranenburgh Rocky M Production of recombinant collagenases colg and colh in escherichia coli
US10071143B1 (en) 2007-05-03 2018-09-11 The Research Foundation For The State University Of New York Methods for non-surgical treatment of carpal tunnel syndrome
TWI395593B (zh) 2008-03-06 2013-05-11 Halozyme Inc 可活化的基質降解酵素之活體內暫時性控制
US20110229451A2 (en) * 2009-03-06 2011-09-22 Halozyme, Inc. Temperature sensitive mutants of matrix metalloproteases and uses thereof
WO2010111525A2 (en) 2009-03-25 2010-09-30 Agee, John, M., Trustee Of The John M. Agee Trust Of August 15, 1996 Treatment of carpal tunnel syndrome by injection of the flexor retinaculum
ES2385239B1 (es) 2010-09-30 2013-06-19 Proteos Biotech S.L.U. Uso de colagenasa g recombinante, colagenasa h recombinante y pz-peptidasa recombinante para el tratamiento de enfermedades que cursan con alteraciones del colágeno.
ES2715204T3 (es) 2010-10-30 2019-06-03 Univ Oxford Innovation Ltd Tratamiento de la enfermedad de Dupuytren
CN103687607B (zh) 2011-07-20 2018-01-30 麦迪伍德有限公司 用于治疗结缔组织疾患的来自菠萝蛋白酶的蛋白水解提取物
GB201119089D0 (en) 2011-11-04 2011-12-21 Isis Innovation Treatment of musculoskeletal fibroproliferative disorders
EP4276180B1 (en) 2012-01-12 2026-04-22 Endo Biologics Limited Clostridium histolyticum enzyme
WO2014066622A2 (en) 2012-10-24 2014-05-01 The Research Foundation For The State University Of New York Use of collagenase to treat glaucoma
US20150196625A9 (en) 2013-01-07 2015-07-16 Rudolph D. Paladini Metal Sensitive Mutants of Matrix Metalloproteases and uses thereof
US9744138B2 (en) 2013-03-15 2017-08-29 Biospecifics Technologies Corp. Treatment method and product for uterine fibroids using purified collagenase
AU2015101954A4 (en) * 2015-01-06 2020-04-30 Harrow Ip, Llc Pharmaceutical formulations of xanthine or xanthine derivatives
WO2017027867A2 (en) 2015-08-13 2017-02-16 City Of Hope Methods, compositions, and kits for detection of bacterial proteases
IL327169A (en) 2017-03-01 2026-05-01 Endo Ventures Ltd A method for assessing and treating cellulite
US11473074B2 (en) 2017-03-28 2022-10-18 Endo Global Aesthetics Limited Method of producing collagenase
CA3157517A1 (en) 2019-10-15 2021-04-22 The Johns Hopkins University Treatment of uterine fibroids using purified collagenase

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3678158A (en) * 1971-05-11 1972-07-18 Worthington Bio Chem Corp Treatment of herniated intervertebral discs of mammals
SU706090A1 (ru) * 1976-06-08 1979-12-30 Центральный научно-исследовательский институт травматологии и ортопедии им. Н.Н.Приорова Способ лечени контрактуры дюпюитрена
US4174389A (en) * 1977-05-13 1979-11-13 Cope Louise A Ophthalmic use of collagenase
US4338300A (en) * 1981-02-05 1982-07-06 The Regents Of The University Of California Use of purified clostridial collangenase in the treatment of Peyronie's disease
US4485088A (en) * 1982-03-26 1984-11-27 Bio-Products, Inc. Method of treatment of fibrotic lesions by topical administration of lathyrogenic drugs
US4524065A (en) * 1983-08-04 1985-06-18 Bio-Specifics N.V. Method for the prevention and treatment of scars with enzymes
US4645668A (en) * 1983-08-04 1987-02-24 Biospecifics, Nv Method for the prevention and treatment of scars with enzymes
US5173295A (en) * 1990-10-05 1992-12-22 Advance Biofactures Of Curacao, N.V. Method of enhancing the regeneration of injured nerves and adhesive pharamaceutical formulation therefor
RU2005488C1 (ru) * 1992-06-16 1994-01-15 Российская фармацевтическая компания "Фарма" Средство для лечения болезней соединительной ткани

Also Published As

Publication number Publication date
DE19530832A1 (de) 1996-02-29
GB2292521A (en) 1996-02-28
FI953915A0 (fi) 1995-08-21
FI953915L (fi) 1996-02-23
GB9516214D0 (en) 1995-10-11
US5589171A (en) 1996-12-31
SE9502893D0 (sv) 1995-08-21
FI953915A7 (fi) 1996-02-23
NO953262L (no) 1996-02-23
NO953262D0 (no) 1995-08-18
DK89395A (da) 1996-02-23

Similar Documents

Publication Publication Date Title
SE9502893D0 (sv) Användning av kollagenas
EP0677036A4 (en) PRODUCTION OF ODOR-FREE TETRAHYDROISOCUMULATES.
EP0786995A4 (da)
ES2157992T3 (es) Alcoxi-alquil-carbamatos de imidazo(1,2-a)piridinas.
ATE198477T1 (de) Benzothiophenderivate
BR9611472A (pt) Compostos de di-terc-butilfenol contendo enxofre úteis como agentes antiinflamatórios
BR9612074A (pt) Novos 4-(1h-benzimidazol-2-il)(1,4) diazepanos substituidos úteis para o tratamento de doenças alérgicas
NO940190L (no) Anvendelse av alpha-ketoglutarat
NO942756D0 (no) Behandling av glaucoma
ITTO930806A1 (it) Purificazione dell' 1, 1-dicloro-1-fluoroetano.
EP0800396A4 (en) TREATMENT OF HYPERANDROGEN STATES
NO924694L (no) 1-piperidinylalkanoylarylsulfonamidderivater
FR2707165B1 (fr) Application des taxoides au traitement de maladies d'origine parasitaire .
FR2691359B1 (fr) Nouvelle application therapeutique du malate de 1-citrulline.
DK0625969T3 (da) Arylalkoxyphenoxyimidazolinforbindelser
FI964219A0 (fi) Huovankäsittely - epäorgaanisen kerrostuman esto suihkukäsittelyllä
ITPG950031U1 (it) Manico per cappuccio di siringa
IT1255639B (it) Uso dell'oxatomide come agente antitosse
UA1034S (uk) Міні-пальто хутрове жіноче
UA994S (uk) Міні-пальто хутрове жіноче
UA1185S (uk) Міні-пальто жіноче хутрове
UA1032S (uk) Міні-пальто хутрове жіноче
UA1189S (uk) Міні-пальто жіноче хутрове
UA1033S (uk) Міні-пальто хутрове жіноче
ITCT920019A0 (it) L'esempio dell umanita

Legal Events

Date Code Title Description
NAV Patent application has lapsed

Ref document number: 9502893-2

Format of ref document f/p: F